Jpmorgan Chase & CO Shattuck Labs, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding STTK
# of Institutions
77Shares Held
26.7MCall Options Held
3.1KPut Options Held
23.9K-
Redmile Group, LLC San Francisco, CA5.62MShares$6.51 Million1.41% of portfolio
-
Prosight Management, LP Dallas, TX4.67MShares$5.42 Million5.63% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.75MShares$3.18 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$2.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.3MShares$2.67 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $49.2M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...